|
| | Publication Year | Title | Author(s) |
| 41 | Aug-2018 | Adapting an Established Clinical Chemistry Quality Control Measure for Droplet Generation Performance in Digital PCR. | Goh, Su Kah ; Wong, Boris Ka Leong; Muralidharan, Vijayaragavan ; Christophi, Christopher ; Do, Hongdo; Dobrovic, Alexander |
| 42 | Feb-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Anton, Angelyn; Nottage, Michelle; Wong, Vanessa ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Lombard, Janine M; Gibbs, Peter; Gately, Lucy |
| 43 | 31-Jan-2023 | Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. | Herbst, Roy S; Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vu, Huu Vinh; Lu, Shun; Lee, Kye Young; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Urban, Damien; Huang, Xiangning; Bolanos, Ana; Stachowiak, Marta; Tsuboi, Masahiro |
| 44 | May-2022 | Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage. | Balasubramanian, Adithya ; Gunjur, Ashray ; Weickhardt, Andrew J ; Papa, Nathan; Bolton, Damien M ; Lawrentschuk, Nathan; Perera, Marlon |
| 45 | 1-Dec-2016 | Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial | Johnson, Stephanie; Clayton, Josephine M; Butow, Phyllis N; Silvester, William; Detering, Karen M ; Hall, Jane; Kiely, Belinda E; Cebon, Jonathan S ; Clarke, Stephen; Bell, Melanie L; Stockler, Martin R; Beale, Phillip; Tattersall, Martin HN |
| 46 | Mar-2023 | ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature. | Galea, Laurence A; Hildebrand, Michael S ; Witkowski, Tom ; Joy, Christopher; McEvoy, Christopher R; Hanegbi, Uri; Aga, Ahmad |
| 47 | Jun-2016 | Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity. | Yao, Jun; Caballero, Otavia L; Huang, Ying; Lin, Calvin; Rimoldi, Donata; Behren, Andreas; Cebon, Jonathan S ; Hung, Mien-Chie; Weinstein, John N; Strausberg, Robert L; Zhao, Qi |
| 48 | 2018 | An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma. | Wight, Joel C ; Hawkes, Eliza A ; Berlangieri, Salvatore U ; Khor, Richard ; Grigg, Andrew P |
| 49 | 5-Aug-2015 | An optimised direct lysis method for gene expression studies on low cell numbers. | Le, Anh Viet-Phuong; Huang, Dexing; Blick, Tony; Thompson, Erik W; Dobrovic, Alexander |
| 50 | 27-Feb-2023 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. | Chmielecki, Juliann; Mok, Tony; Wu, Yi-Long; Han, Ji-Youn; Ahn, Myung-Ju; Ramalingam, Suresh S; John, Thomas ; Okamoto, Isamu; Yang, James Chih-Hsin; Shepherd, Frances A; Bulusu, Krishna C; Laus, Gianluca; Collins, Barbara; Barrett, J Carl; Hartmaier, Ryan J; Papadimitrakopoulou, Vassiliki |
| 51 | Dec-2020 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Chia, Puey Ling ; Russell, Prudence; Asadi, Khashi; Thapa, Bibhusal ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Eriksson, Ulf; Scott, Andrew M ; John, Thomas |
| 52 | 27-Mar-1995 | Angiotensin II receptor subtypes in the human central nervous system. | MacGregor, Duncan; Murone, Carmel ; Song, K; Allen, A M; Paxinos, G; Mendelsohn, Frederick AO |
| 53 | May-2017 | Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes. | Tu, Yan; Johnstone, Cameron N ; Stewart, Alastair G |
| 54 | 8-Mar-2021 | Annexin A1 Is Required for Efficient Tumor Initiation and Cancer Stem Cell Maintenance in a Model of Human Breast Cancer. | Johnstone, Cameron N ; Tu, Yan; Langenbach, Shenna; Baloyan, David; Pattison, Andrew D; Lock, Peter; Britt, Kara L; Lehmann, Brian D; Beilharz, Traude H; Ernst, Matthias ; Anderson, Robin L ; Stewart, Alastair G |
| 55 | 20-Feb-2014 | Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity. | Ung, Nelson; Putoczki, Tracy L; Stylli, Stanley S; Ng, Irvin; Mariadason, John M ; Chan, Timothy A; Zhu, Hong-Jian; Luwor, Rodney B |
| 56 | 5-Sep-2019 | Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature. | Gunjur, Ashray ; Klein, Oliver ; Kee, Damien ; Cebon, Jonathan S |
| 57 | 1-Mar-2002 | Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. | Liu, Zhanqi; Smyth, Fiona E; Renner, Christoph; Lee, Fook-Thean; Oosterwijk, Egbert; Scott, Andrew M |
| 58 | 5-Apr-2011 | Antibodies in oncology. | Pillay, Vinochani; Gan, Hui K ; Scott, Andrew M |
| 59 | 23-Nov-2023 | Antibody and immunotherapy in diffuse large B-cell lymphoma. | Barraclough, Allison ; Hawkes, Eliza A |
| 60 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
